LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | +64.3% | 391 | +105.8% | 0.00% | – |
| Q2 2023 | $14 | +7.7% | 190 | +3.8% | 0.00% | – |
| Q1 2023 | $13 | +8.3% | 183 | +4.0% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 176 | +10.7% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 159 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | +27.3% | 159 | +59.0% | 0.00% | – |
| Q1 2022 | $11,000 | -47.6% | 100 | -24.8% | 0.00% | – |
| Q4 2021 | $21,000 | – | 133 | +6550.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 2 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 2 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |